Intrinsic value of Natural Health Trends - NHTC

Previous Close

$18.55

  Intrinsic Value

$75.00

stock screener

  Rating & Target

str. buy

+304%

  Value-price divergence*

0%

Previous close

$18.55

 
Intrinsic value

$75.00

 
Up/down potential

+304%

 
Rating

str. buy

 
Value-price divergence*

0%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of NHTC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.2

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  8.68
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  288
  294
  301
  308
  317
  327
  337
  349
  361
  374
  389
  404
  420
  438
  457
  476
  497
  519
  543
  567
  593
  621
  650
  680
  713
  746
  782
  820
  859
  901
  945
Variable operating expenses, $m
 
  90
  92
  94
  97
  100
  103
  107
  110
  114
  119
  123
  128
  134
  139
  145
  152
  159
  166
  173
  181
  190
  198
  208
  218
  228
  239
  250
  262
  275
  288
Fixed operating expenses, $m
 
  142
  146
  150
  153
  157
  161
  165
  169
  174
  178
  182
  187
  192
  196
  201
  206
  212
  217
  222
  228
  233
  239
  245
  251
  258
  264
  271
  278
  284
  292
Total operating expenses, $m
  224
  232
  238
  244
  250
  257
  264
  272
  279
  288
  297
  305
  315
  326
  335
  346
  358
  371
  383
  395
  409
  423
  437
  453
  469
  486
  503
  521
  540
  559
  580
Operating income, $m
  64
  61
  63
  64
  67
  69
  73
  77
  81
  86
  92
  98
  105
  113
  121
  130
  139
  149
  160
  172
  184
  198
  212
  227
  244
  261
  279
  299
  319
  341
  365
EBITDA, $m
  64
  62
  63
  65
  67
  70
  73
  77
  82
  87
  92
  98
  105
  113
  121
  130
  139
  149
  160
  172
  185
  198
  212
  228
  244
  261
  279
  299
  320
  342
  365
Interest expense (income), $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  1
  1
  1
  1
  1
  1
  1
  2
  2
  2
  2
  2
  3
  3
  3
  3
  4
  4
  4
Earnings before tax, $m
  64
  61
  63
  64
  67
  69
  73
  77
  81
  86
  92
  98
  105
  112
  120
  129
  138
  148
  159
  170
  183
  196
  210
  225
  241
  258
  276
  295
  316
  338
  361
Tax expense, $m
  9
  17
  17
  17
  18
  19
  20
  21
  22
  23
  25
  26
  28
  30
  32
  35
  37
  40
  43
  46
  49
  53
  57
  61
  65
  70
  75
  80
  85
  91
  97
Net income, $m
  55
  45
  46
  47
  49
  51
  53
  56
  59
  63
  67
  71
  76
  82
  88
  94
  101
  108
  116
  124
  133
  143
  153
  164
  176
  188
  202
  216
  231
  246
  263

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  126
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  148
  67
  69
  71
  73
  75
  77
  80
  83
  86
  89
  93
  96
  100
  105
  109
  114
  119
  124
  130
  136
  142
  149
  156
  163
  171
  179
  188
  197
  206
  216
Adjusted assets (=assets-cash), $m
  22
  67
  69
  71
  73
  75
  77
  80
  83
  86
  89
  93
  96
  100
  105
  109
  114
  119
  124
  130
  136
  142
  149
  156
  163
  171
  179
  188
  197
  206
  216
Revenue / Adjusted assets
  13.091
  4.388
  4.362
  4.338
  4.342
  4.360
  4.377
  4.363
  4.349
  4.349
  4.371
  4.344
  4.375
  4.380
  4.352
  4.367
  4.360
  4.361
  4.379
  4.362
  4.360
  4.373
  4.362
  4.359
  4.374
  4.363
  4.369
  4.362
  4.360
  4.374
  4.375
Average production assets, $m
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  1
  2
  2
  2
  2
  2
  2
  2
  2
  2
  2
  2
  3
  3
  3
Working capital, $m
  84
  -29
  -30
  -31
  -32
  -33
  -34
  -35
  -36
  -37
  -39
  -40
  -42
  -44
  -46
  -48
  -50
  -52
  -54
  -57
  -59
  -62
  -65
  -68
  -71
  -75
  -78
  -82
  -86
  -90
  -94
Total debt, $m
  0
  -5
  -4
  -2
  -1
  1
  4
  6
  8
  11
  14
  17
  21
  24
  28
  32
  37
  41
  46
  51
  56
  62
  68
  74
  81
  88
  95
  103
  111
  120
  129
Total liabilities, $m
  66
  61
  62
  64
  65
  67
  70
  72
  74
  77
  80
  83
  87
  90
  94
  98
  103
  107
  112
  117
  122
  128
  134
  140
  147
  154
  161
  169
  177
  186
  195
Total equity, $m
  82
  7
  7
  7
  7
  7
  8
  8
  8
  9
  9
  9
  10
  10
  10
  11
  11
  12
  12
  13
  14
  14
  15
  16
  16
  17
  18
  19
  20
  21
  22
Total liabilities and equity, $m
  148
  68
  69
  71
  72
  74
  78
  80
  82
  86
  89
  92
  97
  100
  104
  109
  114
  119
  124
  130
  136
  142
  149
  156
  163
  171
  179
  188
  197
  207
  217
Debt-to-equity ratio
  0.000
  -0.800
  -0.580
  -0.340
  -0.090
  0.180
  0.450
  0.740
  1.020
  1.310
  1.590
  1.870
  2.150
  2.420
  2.690
  2.950
  3.210
  3.450
  3.690
  3.920
  4.150
  4.360
  4.570
  4.770
  4.960
  5.140
  5.320
  5.490
  5.650
  5.800
  5.950
Adjusted equity ratio
  -2.000
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  55
  45
  46
  47
  49
  51
  53
  56
  59
  63
  67
  71
  76
  82
  88
  94
  101
  108
  116
  124
  133
  143
  153
  164
  176
  188
  202
  216
  231
  246
  263
Depreciation, amort., depletion, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Funds from operations, $m
  50
  45
  46
  47
  49
  51
  53
  56
  59
  63
  67
  72
  76
  82
  88
  94
  101
  108
  116
  124
  133
  143
  153
  164
  176
  189
  202
  216
  231
  247
  263
Change in working capital, $m
  -3
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -4
Cash from operations, $m
  53
  46
  47
  48
  50
  52
  54
  57
  61
  64
  69
  73
  78
  84
  90
  96
  103
  110
  118
  127
  136
  146
  156
  167
  179
  192
  205
  220
  235
  251
  268
Maintenance CAPEX, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
New CAPEX, $m
  -1
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from investing activities, $m
  -1
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Free cash flow, $m
  52
  46
  47
  48
  50
  52
  54
  57
  61
  64
  68
  73
  78
  83
  89
  96
  103
  110
  118
  127
  136
  146
  156
  167
  179
  192
  205
  219
  234
  250
  267
Issuance/(repayment) of debt, $m
  0
  -5
  1
  2
  2
  2
  2
  2
  3
  3
  3
  3
  3
  4
  4
  4
  4
  5
  5
  5
  5
  6
  6
  6
  7
  7
  7
  8
  8
  9
  9
Issuance/(repurchase) of shares, $m
  -24
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -24
  -5
  1
  2
  2
  2
  2
  2
  3
  3
  3
  3
  3
  4
  4
  4
  4
  5
  5
  5
  5
  6
  6
  6
  7
  7
  7
  8
  8
  9
  9
Total cash flow (excl. dividends), $m
  28
  40
  48
  50
  51
  54
  56
  60
  63
  67
  71
  76
  81
  87
  93
  100
  107
  115
  123
  132
  141
  151
  162
  174
  186
  199
  212
  227
  243
  259
  276
Retained Cash Flow (-), $m
  -25
  -7
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
Prev. year cash balance distribution, $m
 
  82
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  116
  48
  49
  51
  54
  56
  59
  63
  67
  71
  76
  81
  87
  93
  99
  106
  114
  122
  131
  141
  151
  161
  173
  185
  198
  212
  226
  242
  258
  275
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  111
  44
  43
  42
  42
  41
  40
  39
  38
  37
  36
  35
  33
  31
  29
  27
  25
  23
  20
  18
  16
  13
  11
  9
  8
  6
  5
  4
  3
  2
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand name in the United States, Canada, Hong Kong, China, Taiwan, South Korea, Russia, Kazakhstan, Ukraine, and internationally. Its wellness products include liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprise herbal supplements. The company’s beauty products consists of anti-aging and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products include weight management, intimacy support, and energy enhancing supplements. In addition, it offers home and car appliances. The company sells its products through its network marketing operations, as well as sells directly to consumers through an e-commerce platform. Natural Health Trends Corp. was founded in 1988 and is headquartered in Rolling Hills Estates, California.

FINANCIAL RATIOS  of  Natural Health Trends (NHTC)

Valuation Ratios
P/E Ratio 3.8
Price to Sales 0.7
Price to Book 2.6
Price to Tangible Book
Price to Cash Flow 4
Price to Free Cash Flow 4
Growth Rates
Sales Growth Rate 8.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 0%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio 0.1
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 40.4%
Ret/ On Assets - 3 Yr. Avg. 49.4%
Return On Total Capital 79.1%
Ret/ On T. Cap. - 3 Yr. Avg. 105.8%
Return On Equity 79.1%
Return On Equity - 3 Yr. Avg. 105.8%
Asset Turnover 2.1
Profitability Ratios
Gross Margin 80.9%
Gross Margin - 3 Yr. Avg. 79.6%
EBITDA Margin 22.2%
EBITDA Margin - 3 Yr. Avg. 19%
Operating Margin 22.2%
Oper. Margin - 3 Yr. Avg. 19%
Pre-Tax Margin 22.2%
Pre-Tax Margin - 3 Yr. Avg. 19%
Net Profit Margin 19.1%
Net Profit Margin - 3 Yr. Avg. 17.6%
Effective Tax Rate 14.1%
Eff/ Tax Rate - 3 Yr. Avg. 7%
Payout Ratio 12.7%

NHTC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the NHTC stock intrinsic value calculation we used $288 million for the last fiscal year's total revenue generated by Natural Health Trends. The default revenue input number comes from 2016 income statement of Natural Health Trends. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our NHTC stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for NHTC is calculated based on our internal credit rating of Natural Health Trends, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Natural Health Trends.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of NHTC stock the variable cost ratio is equal to 30.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $139 million in the base year in the intrinsic value calculation for NHTC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Natural Health Trends.

Corporate tax rate of 27% is the nominal tax rate for Natural Health Trends. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the NHTC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for NHTC are equal to 0.3%.

Life of production assets of 10 years is the average useful life of capital assets used in Natural Health Trends operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for NHTC is equal to -10%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $82 million for Natural Health Trends - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 11.131 million for Natural Health Trends is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Natural Health Trends at the current share price and the inputted number of shares is $0.2 billion.

RELATED COMPANIES Price Int.Val. Rating
USNA USANA Health S 56.55 89.06  buy
NUS Nu Skin Enterp 55.48 85.70  buy
MTEX Mannatech 15.65 61.60  str.buy
IPAR Inter Parfums 37.75 68.65  str.buy
NUTR Nutraceutical 41.80 27.42  sell
HLF Herbalife 61.95 67.76  hold
LCUT Lifetime Brand 16.80 11.45  sell
GAIA Gaia Cl A 11.50 1.41  str.sell
PCMI PCM 12.15 56.05  str.buy

COMPANY NEWS

▶ Natural Health Trends posts 2Q profit   [Aug-02-17 10:37PM  Associated Press]
▶ Natural Health Trends posts 1Q profit   [05:01AM  Associated Press]
▶ Natural Health Trends posts 4Q profit   [Feb-08-17 09:13AM  Associated Press]
▶ Twitter Is Poised to Slay the Bears Soon   [Feb-06-17 04:53PM  TheStreet.com]
▶ Is Natural Health Trends Corp. (NHTC) A Good Stock To Buy?   [Dec-10-16 08:38AM  at Insider Monkey]
▶ 5 Stocks Ripe For Activist Takeovers   [11:08AM  at Insider Monkey]
▶ Top Ten 'Magic Formula' Stocks For Long-Term Returns   [Nov-14-16 12:34PM  at Forbes]
▶ Natural Health Trends Celebrates 15th Anniversary   [Aug-18-16 09:00AM  GlobeNewswire]
Stock chart of NHTC Financial statements of NHTC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.